Health Disparities in Utilization, Quality, and Outcomes for Three Common Ocular Conditions (HealthDOC)

三种常见眼部疾病的利用、质量和结果方面的健康差异 (HealthDOC)

基本信息

  • 批准号:
    10559239
  • 负责人:
  • 金额:
    $ 46.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: Multiple that minority CHIP of The understood. ophthalmology retinopathy. past studies provide strong evidence that disparities exist in healthcare, i ncluding in ophthalmology, and social determinant of health (SDH) play an important role for explaining differences in ethnic and racial receipt of healthcare. With the passage of the Affordable Care Act and later the Medicare Access and Reauthorization Act of 2015, there has been emphasis on medical quality measures with implementation the Medicare Incentive Payment System (MIPS) with the use of National Quality Forum (NQF) related metrics. association between quality measures for ophthalmic conditions and healthcare disparities is poorly In fact, there has been little research to inform how the social determinants of health impact care practices and quality metrics by racial/ethnic groups with cataract, glaucoma, and diabetic The proposedHealth Disparities in Utilization, Quality, and Outcomes for Three Common Ocular Conditions (HealthDOC) study employing clinically will address prevailing gaps between clinical quality measures and practice by a rigorous health services and outcomes research study design that evaluates ophthalmic NQF, and meaningful measures using the S ight OU tcomes R esearch C ollaborativ E ( SOURCE to study health) disparities. SOURCE links and extracts data across healthcare systems from electronic health records to capture visual changes, clinical details (typically not available but through clinical trials), and health disparities, which is ideal for responding to Healthy People 2030 ocular goals. SOURCE overcomes major data barriers in ophthalmology health disparities work with visual outcome details for measuring treatment, quality, and outcomes, joined with key information on race and ethnicity, the biological variable of gender, SDH measures, medications, hemoglobin A1c, Centers for Disease Control National Death Index Data and others. This study will examine three major eye diseases (cataract, glaucoma, diabetic eye disease) and quantify the impact of SDH on achievement of established and peer reviewed NQF ocular quality metrics, and clinically meaningful measures on visual outcomes, and non-ocular morbidity and mortality for the chronic diseases of glaucoma and diabetic retinopathy. The ocular conditions we focus on are the most common causes of irreversible visual impairment and blindness in the U.S. and fulfills the target goals for National Eye Institute and Healthy People 2030. This on Eye Care Disparities), leveraging states disparities National innovative, 2 stakeholder-driven 3 ) aligned with healthcare management using accepted quality metrics (NQF), and 4 existing data from electronic health records of 27 ophthalmology program sites covering multiple and regions, focused on quality improvement initiatives aimed at future interventions to reduce health across SOURCE sites and abroad. This project aligns well with the missions of the NIH, NEI, and Academy of Medicine (NAM) on reducing health disparities and the prevention of vision loss. study is: 1) ) (American Academy of Ophthalmology, Task Force )
项目摘要/摘要: 多种的 那 少数民族 芯片 的 这 明白了。 眼科 视网膜病变。 过去的研究提供了强有力的证据表明医疗保健领域存在差异,包括眼科和 健康的社会决定因素(SDH)在解释民族和种族差异方面发挥着重要作用 医疗保健收据。随着平价医疗法案和后来的医疗保险法案的通过 2015年再授权法案强调医疗质量措施的实施 医疗保险激励支付系统 (MIPS) 并使用国家质量论坛 (NQF) 相关指标。 眼科疾病的质量测量与医疗保健差异之间的关联性较差 事实上,很少有研究表明健康的社会决定因素如何影响 患有白内障、青光眼和糖尿病的种族/族裔群体的护理实践和质量指标 拟议的三种常见眼科疾病在利用、质量和结果方面的健康差异 条件 (HealthDOC) 研究 雇用 临床上 将通过以下方式解决临床质量措施与实践之间普遍存在的差距 评估眼科 NQF 的严格健康服务和结果研究设计,以及 使用 Sight OU tcomes Research Collaborativ E(健康研究来源)采取有意义的措施 差异。 SOURCE 从电子健康记录中链接和提取跨医疗保健系统的数据以捕获 视觉变化、临床细节(通常无法获得,但通过临床试验)和健康差异,这是 非常适合响应“健康人 2030”眼部目标。 SOURCE 克服了主要数据障碍 眼科健康差异与视觉结果细节一起用于衡量治疗、质量和 结果,结合有关种族和民族、性别生物变量、SDH 措施的关键信息, 药物、血红蛋白 A1c、疾病控制中心国家死亡指数数据等。这项研究 将检查三种主要眼病(白内障、青光眼、糖尿病眼病)并量化其影响 SDH 实现既定且经过同行评审的 NQF 眼部质量指标,并具有临床意义 青光眼等慢性疾病的视力结果以及非眼部发病率和死亡率的衡量标准 糖尿病视网膜病变。我们关注的眼部疾病是导致不可逆视力的最常见原因 在美国减少视力障碍和失明,并实现国家眼科研究所和健康人群的目标 2030.这 关于眼睛护理差异), 杠杆作用 州 差异 国家的 创新,2 利益相关者驱动 3 ) 使用公认的质量指标 (NQF) 与医疗保健管理保持一致,以及 4 现有数据来自 27 个眼科项目站点的电子健康记录,涵盖多个领域 和地区,重点关注质量改进举措,旨在未来采取干预措施,以减少健康 跨来源网站和国外。该项目与 NIH、NEI 和 美国医学会 (NAM) 致力于减少健康差异和预防视力丧失。 研究是:1) )(美国眼科学会,工作组 )

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DUSTIN D. FRENCH其他文献

DUSTIN D. FRENCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DUSTIN D. FRENCH', 18)}}的其他基金

Understanding Diabetic Eye Disease in the Underserved Using Health Data Exchange
使用健康数据交换了解服务不足的地区的糖尿病眼病
  • 批准号:
    8769287
  • 财政年份:
    2014
  • 资助金额:
    $ 46.43万
  • 项目类别:
Understanding Diabetic Eye Disease in the Underserved Using Health Data Exchange
使用健康数据交换了解服务不足的地区的糖尿病眼病
  • 批准号:
    8928622
  • 财政年份:
    2014
  • 资助金额:
    $ 46.43万
  • 项目类别:

相似海外基金

Measuring and Reducing Excessive Infant Crying: A Randomized Trial
测量和减少婴儿过度哭泣:随机试验
  • 批准号:
    7962795
  • 财政年份:
    2010
  • 资助金额:
    $ 46.43万
  • 项目类别:
Measuring and Reducing Excessive Infant Crying: A Randomized Trial
测量和减少婴儿过度哭泣:随机试验
  • 批准号:
    8277934
  • 财政年份:
    2010
  • 资助金额:
    $ 46.43万
  • 项目类别:
Measuring and Reducing Excessive Infant Crying: A Randomized Trial
测量和减少婴儿过度哭泣:随机试验
  • 批准号:
    8117157
  • 财政年份:
    2010
  • 资助金额:
    $ 46.43万
  • 项目类别:
Measuring and Reducing Excessive Infant Crying: A Randomized Trial
测量和减少婴儿过度哭泣:随机试验
  • 批准号:
    8676838
  • 财政年份:
    2010
  • 资助金额:
    $ 46.43万
  • 项目类别:
Measuring and Reducing Excessive Infant Crying: A Randomized Trial
测量和减少婴儿过度哭泣:随机试验
  • 批准号:
    8462283
  • 财政年份:
    2010
  • 资助金额:
    $ 46.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了